Effect of 4 years of growth hormone therapy in children with Noonan syndrome in the American Norditropin Studies: Web-Enabled Research (ANSWER) Program® registry

by Lee, Peter A, Ross, Judith, Germak, John A, Gut, Robert
Published 2012

Increased height standard deviation scores in response to growth hormone therapy to near-adult height in older children with delayed skeletal maturation: results from the ANSWER Pr...

by Ross, Judith L, Lee, Peter A, Gut, Robert, Germak, John
Published 2015

Identification of factors associated with good response to growth hormone therapy in children with short stature: results from the ANSWER Program®

by Lee, Peter A, Germak, John, Gut, Robert, Khutoryansky, Naum, Ross, Judith
Published 2011

Noonan syndrome and Turner syndrome patients respond similarly to 4 years’ growth-hormone therapy: longitudinal analysis of growth-hormone-naïve patients enrolled in the NordiNet®...

by Lee, Peter A., Ross, Judith L., Pedersen, Birgitte Tønnes, Kotnik, Primoz, Germak, John A., Christesen, Henrik T.
Published 2015

Dose-sparing and safety-enhancing effects of an IGF-I-based dosing regimen in short children treated with growth hormone in a 2-year randomized controlled trial: therapeutic and ph...

by Cohen, Pinchas, Weng, Wayne, Rogol, Alan D, Rosenfeld, Ron G, Kappelgaard, Anne-Marie, Germak, John
Published 2014

The NordiNet® International Outcome Study and NovoNet® ANSWER Program®: rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monit...

by Höybye, Charlotte, Sävendahl, Lars, Christesen, Henrik Thybo, Lee, Peter, Pedersen, Birgitte Tønnes, Schlumpf, Michael, Germak, John, Ross, Judith
Published 2013